LatchBio is a biotech research company that provides code-free platform for the biocomputing revolution.
LatchBio has raised $28.0M in total funding. The most recent round was Series A. The last funding was announced in June 2022.
LatchBio's investors include General Catalyst, Coatue, Caffeinated Capital, Lux Capital, Hummingbird Ventures.
LatchBio is headquartered in San Francisco, United States.
LatchBio is a biotech research company that provides code-free platform for the biocomputing revolution.
LatchBio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LatchBio — Funding & Investors." VCBacked, June 2, 2022, https://www.vcbacked.co/company/latchbio. Accessed October 23, 2026.
VCBacked. (2022). LatchBio — Funding & Investors. Retrieved October 23, 2026, from https://www.vcbacked.co/company/latchbio
{{cite web |title=LatchBio — Funding & Investors |url=https://www.vcbacked.co/company/latchbio |website=VCBacked |access-date=October 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated